|
mRNA_ID
|
gene_Name
|
drug_ID
|
drug_Name
|
Disease
|
RNA_exp_pattern
|
Evidence
|
Details
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
esophageal squamous cell cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
hepatocellular cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
cholangiocancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
hepatocellular cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
glioblastoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
liver cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
hepatocellular cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
chondrosarcoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
laryngeal squamous cell cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
liver cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
upper urinary urothelial cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
prostate cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
endometrial cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
chronic myeloid leukemia
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
cervical cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
prostate cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
non-small cell lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
hepatocellular cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
non-small cell lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
bladder cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
glioma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
hepatoblastoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
neuroblastoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
glioma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
renal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
cervical cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
osteosarcoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
osteosarcoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
endometrial cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
hepatocellular cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
bladder cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
laryngeal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
lung adenocancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
NA
|
hepatocellular cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000602318
|
LAMTOR5
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000602318
|
LAMTOR5
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000361445
|
MTOR
|
DB06287
|
Temsirolimus
|
chronic pain
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB01590
|
Everolimus
|
huntington＇s disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB01590
|
Everolimus
|
nephrotic syndrome
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00877
|
Sirolimus
|
chronic kidney disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00877
|
Sirolimus
|
hyperthyroidism
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB07810
|
Phloretin
|
chronic renal failure
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00203
|
Sildenafil
|
bronchopulmonary dysplasia
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB12480
|
Betulinic Acid
|
non-alcoholic fatty liver disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB06287
|
Temsirolimus
|
hantavirus pulmonary syndrome
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB06287
|
Temsirolimus
|
diabetic macular edema
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB06287
|
Temsirolimus
|
diabetic retinopathy
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB06287
|
Temsirolimus
|
retinal vein occlusions
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB06287
|
Temsirolimus
|
age-related macular degeneration
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB08815
|
Lurasidone
|
depression
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
Rhynchophylline
|
permanent middle cerebral artery occlusion
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00877
|
Sirolimus
|
inflammation
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00877
|
Sirolimus
|
vascular calcification
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00877
|
Sirolimus
|
non-alcoholic fatty liver disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00877
|
Sirolimus
|
septicemia
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00877
|
Sirolimus
|
choroidal vascular disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00877
|
Sirolimus
|
tuberous sclerosis complex related tumor
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00877
|
Sirolimus
|
chronic kidney disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00398
|
Sorafenib
|
hepatocellular cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00331
|
Metformin
|
multiple sclerosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB01590
|
Everolimus
|
cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00877
|
Sirolimus
|
cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB11840
|
Dalotuzumab
|
breast cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB06233
|
Ridaforolimus
|
breast cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00987
|
Cytarabine
|
high-grade glioma
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB07715
|
Emodin
|
non-alcoholic fatty liver disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
Isoimperatorin
|
osteoarthritis
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB01590
|
Everolimus
|
epilepsy
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB01590
|
Everolimus
|
neuroinflammatory disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00877
|
Sirolimus
|
epilepsy
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00877
|
Sirolimus
|
neuroinflammatory disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00877
|
Sirolimus
|
multiple sclerosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00997
|
Doxorubicin
|
muscle injury
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB01254
|
Dasatinib
|
adult type granulosa cell tumor
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB01590
|
Everolimus
|
adult type granulosa cell tumor
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB01229
|
Paclitaxel
|
adult type granulosa cell tumor
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
Kahweol
|
breast cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB11836
|
Sapanisertib
|
systemic lupus erythematosus
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB11836
|
Sapanisertib
|
lupus nephritis
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00877
|
Sirolimus
|
intractable epilepsy
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
Xenin-25
|
neuroinflammatory disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
Xenin-25
|
cognitive diseases
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00877
|
Sirolimus
|
diabetic pregnancy
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB01590
|
Everolimus
|
diabetic pregnancy
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB12771
|
Hydroxytyrosol
|
cardiovascular disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB01590
|
Everolimus
|
inflammation
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00762
|
Irinotecan
|
colorectal cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
Dioscin
|
autoimmune thyroiditis
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00877
|
Sirolimus
|
left ventricular hypertrophy
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
Tongluo Baoshen formula
|
diabetic kidney disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
Kolaviron
|
type 2 diabete
|
up-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
Psoralea corylifolia
|
musculoskeletal diseases
|
up-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
Shuangyu Tiaozhi Decoction
|
non-alcoholic fatty liver disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB02656
|
LY-294002
|
psoriasis
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB16828
|
MK-2206
|
renal fibrosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB01094
|
Hesperetin
|
doxorubicin-induced testicular toxicity
|
up-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB15588
|
Ursolic acid
|
aortic aneurysm
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB07715
|
Emodin
|
acute lung injury
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
Effective-component compatibility of Bufei Yishen formula I
|
chronic obstructive pulmonary disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB06292
|
Dapagliflozin
|
diabetic cardiomyopathy
|
up-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB04951
|
Pirfenidone
|
intestinal fibrosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00877
|
Sirolimus
|
pulmonary arterial hypertension
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB06655
|
Liraglutide
|
diabetic kidney disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00688
|
Mycophenolate mofetil
|
temporal lobe epilepsy
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB12290
|
Puerarin
|
cardiovascular disease
|
up-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00877
|
Sirolimus
|
airway inflammatory disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00877
|
Sirolimus
|
emphysema
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00331
|
Metformin
|
multiple sclerosis
|
up-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00877
|
Sirolimus
|
glomerulosclerosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB08911
|
Trametinib
|
glomerulosclerosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
Diallyl Disulfide
|
myeloid leukemia
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
Virosecurinine
|
chronic myeloid leukemia
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB05294
|
Vandetanib
|
breast cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB12387
|
OSI-027
|
leukemia
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00877
|
Sirolimus
|
osteosarcoma
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB01590
|
Everolimus
|
ovarian cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB07352
|
Apigenin
|
colon cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB11672
|
Curcumin
|
colorectal cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
NA
|
Diphyllin
|
esophageal cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000361445
|
MTOR
|
DB00331
|
Metformin
|
prostate cancer
|
down-regulated
|
validated
|
more...
|